Large-Scale Purification of Functional Recombinant Human Aquaporin-2
| Title: | Large-Scale Purification of Functional Recombinant Human Aquaporin-2 |
|---|---|
| Authors: | Werten, Paul J.L.; Hasler, Lorenz; Koenderink, Jan B.; Klaassen, Corne H. W.; de Grip, Willem; Engel, Andreas; Deen, Peter M.T. |
| Publisher: | FEBS Letters |
| Date Published: | August 31, 2001 |
| Reference Number: | 517 |
You may, however, read this article at the |
This translation by the NDI Foundation is to assist the lay reader. To provide a clear, accessible interpretation of the original article, we eliminated or simplified some technical detail and complicated scientific language. We concentrated our translation on those aspects of the article dealing directly with NDI. The NDI Foundation thanks the researchers for their work toward understanding and more effectively treating this disorder.
© Copyright NDI Foundation 2007 (JC)
In order to better understand the structure and function of AQP2, and thus to better provide therapeutic treatment or cures when AQP2 malfunctions, researchers must have available to them large amounts of AQP2 for structural analysis. However, as AQP2 only appears in the principal cells of the kidney collecting duct and the male gonad, isolating large amounts of AQP2 from natural sources is impossible. Werten, et al., successfully developed a way to obtain sufficient amounts of structurally and functionally accurate AQP2 for scientific study.
The researchers accomplished this by introducing genetically engineered AQP2 called HT-AQP2 (as it was tagged with a histidine amino acid marker) into a culture comprised of baculovirus and insect cells. Their method is able to produce 0.5 mg of pure HT-AQP2 per liter of their bioreactor culture. Their work should enable researchers to greatly further their understanding of AQP2.



